Evidence for differential effects of apoE3 and apoE4 on HDL metabolism

Journal of Lipid Research

Volumn 43, Issue 11, 2002, Pages 1881-1889

  Hopkins, Paul C R ^a   Huang, Yadong ^a,b   McGuire, James G ^a   Pitas, Robert E ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apolipoprotein A1; Apolipoprotein E; Chylomicron metabolism; HDL metabolism

Indexed keywords

APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN; APOLIPOPROTEIN E;

ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; LIPID ANALYSIS; LIPID DIET; LIPOPROTEIN METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; ANIMAL MODEL; BLOOD; GENE EXPRESSION; GENETICS; GENOTYPE; HUMAN; MACROPHAGE; METABOLISM; MOUSE MUTANT; TRANSGENIC MOUSE;

ANIMALS; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CHOLESTEROL; GENE EXPRESSION; GENOTYPE; HUMANS; LIPOPROTEINS, HDL; MACROPHAGES; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, ANIMAL;

EID: 0036845241     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M200172-JLR200     Document Type: Article

References (39)

1. Mahley, R. W. 1988. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science. 240: 622-630.
2. Dallongeville, J., S. Lussier-Cacan, and J. Davignon. 1992. Modulation of plasma triglyceride levels by apoE phenotype: A meta-analysis. J. Lipid Res. 33: 447-454.
3. Tiret, L., P. de Knijff, H-J. Menzel, C. Ehnholm, V. Nicaud, and L. M. Havekes. 1994. ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations. The EARS Study. Arterioscler. Thromb. 14: 1617-1624.
4. Davignon, J., R. E. Gregg, and C. F. Sing. 1988. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 8: 1-21.
5. Gregg, R. E., L. A. Zech, E. J. Schaefer, D. Stark, D. Wilson, and H. B. Brewer, Jr. 1986. Abnormal in vivo metabolism of apolipoprotein E4 in humans. J. Clin. Invest. 78: 815-821.
6. Knouff, C., M. E. Hinsdale, H. Mezdour, M. K. Altenburg, M. Watanabe, S. H. Quarfordt, P. M. Sullivan, and N. Maeda. 1999. Apo E structure determines VLDL clearance and atherosclerosis risk in mice. J. Clin. Invest. 103: 1579-1586.
7. Mahley, R. W., and Z-S. Ji. 1999. Remnant lipoprotein metabolism: Key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J. Lipid Res. 40: 1-16.
8. Medh, J. D., G. L. Fry, S. L. Bowen, S. Ruben, H. Wong, and D. A. Chappell. 2000. Lipoprotein lipase- and hepatic triglyceride lipase-promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism. J. Lipid Res. 41: 1858-1871.
9. Huang, Y., X. Q. Liu, S. C. Rall, Jr., J. M. Taylor, A. von Eckardstein, G. Assmann, and R. W. Mahley. 1998. Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia. J. Biol. Chem. 273: 26388-26393.
10. Zhang, S. H., R. L. Reddick, J. A. Piedrahita, and N. Maeda. 1992. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 258: 468-471.
11. Plump, A. S.,J. D. Smith, T. Hayek, K. Aalto-Setälä, A. Walsh, J. G. Verstuyft, E. M. Rubin, and J. L. Breslow. 1992. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71: 343-353.
12. Nakashima, Y., A. S. Plump, E. W. Raines, J. L. Breslow, and R. Ross. 1994. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb. 14: 133-140.
13. Basheeruddin, K., C. Rechtoris, and T. Mazzone. 1992. Transcriptional and post-transcriptional control of apolipoprotein E gene expression in differentiating human monocytes. J. Biol. Chem. 267: 1219-1224.
14. Linton, M. F., J. B. Atkinson, and S. Fazio. 1995. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science. 267: 1034-1037.
15. Thorngate, F. E., L. L. Rudel, R. L. Walzem, and D. L. Williams. 2000. Low levels of extrahepatic nonmacrophage apoE inhibit atherosclerosis without correcting hypercholesterolemia in apoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 20: 1939-1945.
16. Bellosta, S., R. W. Mahley, D. A. Sanan, J. Murata, D. L. Newland, J. M. Taylor, and R. E. Pitas. 1995. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice. J. Clin. Invest. 96: 2170-2179.
17. Green, P. H, R., R. M. Glickman, C. D. Saudek, C. B. Blum, and A. R. Tall. 1979. Human intestinal lipoproteins. Studies in chyluric subjects. J. Clin. Invest. 64: 233-242.
18. Sonnhammer, E. L. L., S. R. Eddy, and R. Durbin. 1997. Pfam: A comprehensive database of protein domain families based on seed alignments. Proteins. 28: 405-420.
19. Schaefer, E. J., M. G. Wetzel, G. Bengtsson, R. O. Scow, H. B. Brewer, Jr., and T. Olivecrona. 1982. Transfer of human lymph chylomicron constituents to other lipoprotein density fractions during in vitro lipolysis. J. Lipid Res. 23: 1259-1273.
20. Goldberg, I. J. 1996. Lipoprotein lipase and lipolysis: Central roles in lipoprotein metabolism and atherogenesis. J. Lipid Res. 37: 693-707.
21. Zhang, S. H., R. L. Reddick, B. Burkey, and N. Maeda. 1994. Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption. J. Clin. Invest. 94: 937-945.
22. Spangenberg, J., and L. K. Curtiss. 1997. Influence of macrophage-derived apoprotein E on plasma lipoprotein distribution of apolipoprotein A-I in apoprotein E-deficient mice. Biochim. Biophys. Acta. 1349: 109-121.
23. Mahley, R. W., K. E. Palaoglu, Z. Atak, J. Dawson-Pepin, A-M. Langlois, V. Cheung, H. Onat, P. Fulks, L. L. Mahley, F. Vakar, S. Özbayrakçi, O. Gökdemir, and W. Winkler. 1995. Turkish Heart Study: Lipids, lipoproteins, and apolipoproteins. J. Lipid Res. 36: 839-859.
24. Small, J. A., C. Bieberich, Z. Ghotbi, J. Hess, G. A. Scangos, and J. E. Clements. 1989. The visna virus long terminal repeat directs expression of a reporter gene in activated macrophages, lymphocytes, and the central nervous systems of transgenic mice. J. Virol. 63: 1891-1896.
25. Nichols, A. V., R. M. Krauss, and T. A. Musliner. 1986. Nondenaturing polyacrylamide gradient gel electrophoresis. Methods Enzymol. 128: 417-431.
26. Huang, Y., A. von Eckardstein, S. Wu, N. Maeda, and G. Assmann. 1994. A plasma lipoprotein containing only apolipoprotein E and with g mobility on electrophoresis releases cholesterol from cells. Proc. Natl. Acad. Sci. USA. 91: 1834-1838.
27. Dansky, H. M., S. A. Charlton, J. L. Sikes, S. C. Heath, R. Simantov, L. F. Levin, P. Shu, K.J. Moore, J. L. Breslow, and J. D. Smith. 1999. Genetic background determines the extent of atherosclerosis in apoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 19: 1960-1968.
28. von Eckardstein, A., Y. Huang, S. Wu, H. Funke, G. Noseda, and G. Assmann. 1995. Reverse cholesterol transport in plasma of patients with different forms of familial HDL deficiency. Arterioscler. Thromb. Vasc. Biol. 15: 691-703.
29. Cullen, P., A. Cigmarella, B. Brennhausen, S. Mohr, G. Assmann, and A. von Eckardstein. 1998. Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol homeostasis in human monocyte-derived macrophages. J. Clin. Invest. 101: 1670-1677.
30. Jeong, T-S., S. L. Schissel, I. Tabas, H. J. Pownall, A. R. Tall, and X-C. Jiang. 1998. Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase. J. Clin. Invest. 101: 905-912.
31. Arai, T., F. Rinninger, L. Varban, V. Fairchild-Huntress, C-P. Liang, W. Chen, T. Seo, R. Deckelbaum, D. Huszar, and A. R. Tall. 1999. Decreased selective uptake of high density lipoprotein cholesteryl esters in apolipoprotein E knock-out mice. Proc. Natl. Acad. Sci. USA. 96: 12050-12055.
32. Steinmetz, A., C. Jakobs, S. Motzny, and H. Kaffarnik. 1989. Differential distribution of apolipoprotein E isoforms in human plasma lipoproteins. Arteriosclerosis. 9: 405-411.
33. Weisgraber, K. H. 1990. Apolipoprotein E distribution among human plasma lipoproteins: Role of the cysteine-arginine interchange at residue 112. J. Lipid Res. 31: 1503-1511.
34. Dichek, H. L., W. Brecht, J. Fan, Z-S. Ji, S. P. A. McCormick, H. Akeefe, L. Conzo, D. A. Sanan, K. H. Weisgraber, S. G. Young, J. M. Taylor, and R. W. Mahley. 1998. Overexpression of hepatic lipase in transgenic mice decreases apolipoprotein B-containing and high density lipoproteins. Evidence that hepatic lipase acts as a ligand for lipoprotein uptake. J. Biol. Chem. 273: 1896-1903.
35. Clark, A. B., and S. H. Quarfordt. 1985. Apolipoprotein effects on the lipolysis of perfused triglyceride by heparin-immobilized milk lipase. J. Biol. Chem. 260: 4778-4783.
36. Jiang, X-C., O. L. Francone, C. Bruce, R. Milne, J. Mar, A. Walsh, J. L. Breslow, and A. R. Tall. 1996. Increased preb-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes. J. Clin. Invest. 98: 2373-2380.
37. Föger, B., S. Santamarina-Fojo, R. D. Shamburek, C. L. Parrot, G. D. Talley, and H. B. Brewer, Jr. 1997. Plasma phospholipid transfer protein. Adenovirus-mediated overexpression in mice leads to decreased plasma high density lipoprotein (HDL) and enhanced hepatic uptake of phospholipids and cholesteryl esters from HDL. J. Biol. Chem. 272: 27393-27400.
38. Jiang, X-C., C. Bruce, J. Mar, M. Lin, Y. Ji, O. L. Francone, and A. R. Tall. 1999. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. J. Clin. Invest. 103: 907-914.
39. Qin, S., K. Kawano, C. Bruce, M. Lin, C. Bisgaier, A. R. Tall, and X-C. Jiang. 2000. Phospholipid transfer protein gene knock-out mice have low high density lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV-rich lamellar lipoproteins. J. Lipid Res. 41: 269-276.